Ethics and the Business of Biomedicine

During The Last Thirty Years We Have Witnessed Sweeping Changes In Health Care Worldwide, Including New And Expensive Biomedical Technologies, An Increasingly Powerful And Influential Pharmaceutical Industry, Steadily Increasing Health Care Costs In Industrialised Nations, And New Threats To Medical Professionalism. The Essays Collected In This Book Concern Costs And Profits In Relation To Just Health Care, The Often Controversial Practices Of Pharmaceutical Companies, And Corruption In The Professional Practice Of Medicine. Leading Experts Discuss Justice In Relation To Business-friendly Strategies In The Delivery Of Health Care, Access To Life Saving Drugs, The Ethics Of Pharmaceutical Company Marketing Practices, Exploitation In Drug Trials, And Undue Industry Influence Over Medicine. They Offer Guidance Regarding The Ethical Delivery Of Health Care Products And Services By Profit-seeking Organisations Operating In A Global Marketplace, And Recommend Pragmatic Solutions To Enhance Organisational Integrity And Curb Medical Corruption In The Interest Of Patient Welfare.--publisher's Website. Medicine And The Market / Daniel Callahan -- Broken Promises: Do Business-friendly Strategies Frustrate Just Healthcare? / Norman Daniels -- Are Patents An Efficient And Internationally Fair Means Of Funding Research & Development For New Medicines? / Paul T. Menzel -- The Exploitation Of The Economically Disadvantaged In Pharmaceutical Research / Tom L. Beauchamp -- The Dangers Of Detailing: How Pharmaceutical Marketing Threatens Healthcare / Jason E. Hubbard -- The Ethics Of Direct-to-consumer Pharmaceutical Advertising / Denis G. Arnold -- Industry-funded Bioethics And The Limits Of Disclosure / Carl Elliott -- Two Cheers For The Pharmaceutical Industry / Richard T. De George -- The Third Face Of Medicine: Ethics, Business And Challenges To Professionalism / Mary Rorty, Patricia Werhane, Ann Mills -- Theoretical Foundations For Organizational Ethics: Developing Norms For A New Kind Of Healthcare / George Khushf -- A Crisis In Medical Professionalism: Time For Flexner Ii / Daniel Wikler. Edited By Denis G. Arnold. Includes Bibliographical References And Index. During the last thirty years we have witnessed sweeping changes in health care worldwide, including new and expensive biomedical technologies, an increasingly powerful and influential pharmaceutical industry, steadily increasing health care costs in industrialized nations, and new threats to medical professionalism. The essays collected in this book concern costs and profits in relation to just health care, the often controversial practices of pharmaceutical companies, and corruption in the professional practice of medicine. Leading experts discuss justice in relation to business-friendly strategies in the delivery of health care, access to life-saving drugs, the ethics of pharmaceutical company marketing practices, exploitation in drug trials, and undue industry influence over medicine. They offer guidance regarding the ethical delivery of health care products and services by profit-seeking organizations operating in a global marketplace, and recommend pragmatic solutions to enhance organizational integrity and curb medical corruption in the interest of patient welfare The twentieth century saw sweeping changes in health care worldwide, from pharmaceuticals, to new technologies, to increasing health care costs in industrialised nations. These essays examine costs and profits in relation to just health care, the often controversial practices of pharmaceutical companies, and corruption in the professional practice of medicine.